Traditional

NCI’s ComboMATCH initiative will test new drug combinations guided by tumor biology (read)

An Updated Report on the Prevalence of Prior Cancer Among Persons Newly Diagnosed With Cancer in the Surveillance, Epidemiology, and End Results Program  (read)


Strategy May Prevent Tumor Resistance to Targeted Cancer Therapies  (read)


Higher Cancer Rates Found in Military Pilots, Ground Crews (read)

JAMA Oncology latest news (read)

National Cancer Institute latest news
    2023 news releases (read)

   Cancer Currents: An NCI research blog 
    Can Artificial Intelligence See Cancer in New, and Better, Ways (read)

American Cancer Society 
    January 2022 Risk of Dying from Cancer Continues to Drop at an Accelerated Pace (read)

Engineered immune cells deliver anticancer signal, prevent cancer from spreading 
    March 24, 2021 National Cancer Institute  (read more

CAR-T Therapy is approved for treatment of Non-Hodgkins Lymphoma  
    March 16, 2021 Journal of American Medical Association (read more)

Female Breast Cancer Surpasses Lung as the Most Commonly Diagnosed Cancer Worldwide  
    Feb 4, 2021 American Cancer Society  (read more)

Study Finds Missing Regular Mammogram Increases Risk of Death from Breast Cancer  
      Findings Coincide with Plummeting Cancer Rates Due, in Part, to Pandemic Fears and Barriers
      Mar 2, 2021 American Cancer Society (read more)

Statement on Updated USPSTF Lung Cancer Screening Guidelines  
    Mar 9, 2021 (read more)

New treatments spur sharp reduction in lung cancer mortality rate 
    Aug 2020 National Institutes of Health (read more)

Study of “exceptional responders” yields clues to cancer and potential treatments  
    A genomic study has uncovered molecular changes in patient tumors that may give 
    rise to dramatic and long-lasting responses to cancer therapy. Nov 19, 2020  
    National Institutes of Health (read more)



Research Institute Study quantifies impact of  NCI-sponsored trials on clinical cancer care. (9-18-2019) A new study shows that nearly half of phase 3 cancer clinical trials carried out by the National Cancer Institute (NCI)-sponsored SWOG Cancer Research Network, one of five groups in NCI’s National Clinical Trials Network (NCTN), were associated with clinical care guidelines or new drug approvals. NCI is part of the National Institutes of Health. read more

Quest for new cancer treatment crosses milestone.  A cancer therapy for prostate cancer has crossed a milestone in clinical trials, a major development in a decades-long quest to develop a treatment that destroys tumors without the debilitating side effects of chemotherapy, invasive surgery and radiation.  read more

FDA Orders Allergan to Recall Textured Breast Implants Over Cancer Risk
(09-19-2019)The U.S. Food and Drug Administration (FDA) has requested that Allergan recall its BIOCELL textured breast implants due to a risk of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), according to an announcement from the agency. “Although... read more

Top 10 Cancer Hospitals in the United States. (9-13-2019) Each year, U.S. News & World Report releases its annual list of the top 50 hospitals in the United States. In addition to the overall list, the editors highlight facilities that specialize in certain medical fields, including oncology (cancer). All told, around 4,800 U.S. hospitals are considered. read more

Blood Cancer Experts Discuss Latest Treatment Innovations at NCCN 2019 Annual Congress: Hematologic Malignancies
(9-10-2019)  World-renowned experts on blood cancers are meeting in San Francisco on September 27-28, to help clinicians stay up-to-date on new, practice-changing strategies to manage patients with hematologic malignancies … The Annual Congress of the National Comprehensive Cancer Network® (NCCN®), will address new, emerging, and novel therapeutic agents, diagnostics, and other advances in the management of blood cancers. The sessions will also explore the growing role of immunotherapies, biosimilars, personalized medicine, and chemotherapeutic options in a rapidly-changing landscape. read more 


Dense Breast Risk Factor Addressed by FDA.  More than half of women over age 40 have dense breasts, with less fatty tissue and more connective and glandular tissue. That tissue appears white on X-rays, the same color as growths in the breast, making mammograms harder to read. Dense breast tissue is one of the factors that can increase a woman's chances of developing cancer. Under the FDA's proposal, all women would receive a short summary about their breast density. For those with dense breasts, the letter would note that their tissue "makes it harder to find breast cancer," and could require additional testing. The letter would also recommend that they speak with a doctor about their "individual situation." 

Thirty seven states already have laws involving breast-density notifications but the new FDA language would establish a minimum standard that would apply nationwide. The proposal would modernize the agency's oversight of mammography services "by capitalizing on a number of important advances in mammography, like the increased use of 3-D digital screening tools and the need for more uniform breast density reporting."

Providence St. Joseph Medical Center has used a 3-D machine since November 2018. The $357,000 machine was paid for in part by local donations and a portion from a Murdock Charitable Trust Grant.

More info: FDA and National Center for Biotechnology Information NCBI.

Immunotherapy study yield unexpectedly strong results for lung cancer patients. Researchers in Chicago presented new data Monday that has big implications for lung cancer patients. A clinical trial discovered that pairing immunotherapy drugs with standard chemotherapy could significantly increase survival rates in lung cancer patients, Stat reports.

A trial study called Keynote-189 found that newly diagnosed lung cancer patients were 51 percent more likely to be alive in a year if they underwent a regimen that combined Keytruda, an immunotherapy drug by the pharmaceutical company Merck, with standard chemotherapy, than if they received chemotherapy treatment alone. Patients with the combined treatment were also 48 percent less likely to have their cancer progress in that year.

Top 12 Cancer Fighting Foods. Cancer is a curable disease provided it is diagnosed early. However a better option would be to pro actively manage and prevent the birth and multiplication of cancer cells. The following 12 cancer fighting foods could be very useful in preventing the dreaded disease taking roots in the body. Read more.

Consumer Safety Guide was created to keep the public informed about consumer dangers and safety issues associated with numerous products that can cause the public harm. Our website is constantly being updated with the most recent information on the most popular prescription medications and FDA-approved medical devices that could be endangering your health or putting your loved ones at risk. Our mission is to keep you informed and help you make the most educated decisions about your health care! Read more...

Alcohol Use and Cancer.  Most people know that heavy drinking can cause health problems. But many people might not know that drinking alcohol also can raise their risk of getting cancer.

Alcohol use has been linked with cancers of the:
Alcohol may also increase the risk of cancers of the pancreas and stomach
For each of these cancers, the more alcohol you drink, the higher your cancer risk. Read more . . .


Nearly Half of Cancer Cases Are Within Your Control, Researchers Say.  Diseases as complicated as cancer are often caused by genetic factors that are out of your control and risk factors that you can change. Now, researchers have calculated just how much of that risk is within a person’s control.

In a study published in CA: A Cancer Journal for Clinicians, researchers led by Dr. Farhad Islami at the American Cancer Society analyzed national cancer data and calculated how much of cancer cases and deaths can be attributed to factors that people can change. These included smoking, exposure to second-hand smoke, being overweight or obese, drinking too much alcohol, eating red and processed meats, eating too few fruits and vegetables, not exercising, exposure to ultraviolet radiation through activities like tanning and six cancer-related infections (including HPV).

Among more than 1.5 million cancers in 2014, 42% were traced to these factors, as well as 45% of deaths in that year. Read more.

Drinking A Lot Has Been Linked to Cancer, Doctors Warn.  
Leading oncologists issued a warning about the connection between drinking and cancer in a new statement.


The statement from the American Society of Clinical Oncology (ASCO), published Tuesday in the Journal of Clinical Oncology, underscores the connection between drinking alcohol and at least seven types of cancer, including cancers of the mouth, throat, esophagus, liver, breast and colon — a connection strong enough, according to the authors, that an estimated 5.5% of new cancer cases worldwide can be traced back to drinking.

While the conclusion is nothing new — research has shown correlations between drinking and cancer formation for years — the statement marks the first time ASCO, a professional organization composed of some of the nation’s top cancer doctors, has added its voice to the conversation. The purpose of the paper, says corresponding author and University of Wisconsin oncologist Noelle LoConte, is to educate doctors, the public and cancer patients.  Read more . . .

 Mesothelioma Veterans Center  United States Military veterans make up over 30 percent of all patients with malignant mesothelioma, caused by exposure to asbestos. Learn more about your benefits options with our VA-accredited claims agents, all free of charge.  Read.

 Latest cancer news from American Cancer Society ... Read

Latest Cinical News…Montana Cancer Center web site... Read

Complementary and integrative medicine…Montana Cancer center web site...
Read

  
FDA Approves First Gene Therapy For Leukemia...The Food and Drug Administration on Wednesday announced what the agency calls a "historic action" — the first approval of a cell-based gene therapy in the United States.

The FDA approved Kymriah, which scientists refer to as a "living drug" because it involves using genetically modified immune cells from patients to attack their cancer.

The drug was approved to treat children and young adults up to age 25 suffering from a form of acute lymphoblastic leukemia who do not respond to standard treatment or have suffered relapses.

The disease is a cancer of blood and bone marrow that is the most common childhood cancer in the United States. About 3,100 patients who are 20 and younger are diagnosed with ALL each year.  Read more.

China Used Crispr to Fight Cancer in a Real, Live Human - Nov 18, 2016

Do you remember President-elect Trump holding forth on the campaign trail about “China beating us at our own game”? Well, it’s true, as long as the game in question is editing human DNA using Crispr/Cas9. China is now using Crispr-edited cells in living, breathing human beings.

Last month, Chinese scientists at Sichuan University injected cancer-fighting, Crispr-modified white blood cells into a patient suffering from metastatic lung cancer. It was just the latest in a line of recent firsts for the People’s Republic of China, following on the heels of the first Crispr-edited monkeys in
early 2014, and the first Crispr-edited human embryos last May. So there it is, Mr. President-elect: Are you going to let China win the race to edit humans?  Read more...

Why the Latest Cancer Drugs May Not Be as Successful as They Seem  - Nov. 9, 2016
Read more...


Olaparib approved for use in Scotland - Nov. 7, 2017
This week the drug olaparib (also known as Lynparza) was approved for use in Scotland for women with ovarian cancer by the Scottish Medicine’s Consortium. Scottish charity Worldwide Cancer Research funded work which kick-started the development of this drug over 20 years ago.  

Read more...

Cancer News
. . .

New Cancer Drugs May Damage the Heart - Nov. 2, 2016Doctors have found a disturbing downside to some powerful new drugs that harness the immune system to fight cancer: In rare cases, they may cause potentially fatal heart damage, especially when used together.  Read more...

Cancer / Oncology News. Medical News Today.  Read more...
The latest cancer and oncology research from prestigious universities and journals throughout the world.

Cancer Currents: An NCI Cancer Research Blog...
Read more...

Smoking Kills More Southerners, Study Finds  -- Oct. 24, 2016  
Read more...

Teen Hopes Pioneering Study of Her Genetic Cancer Risk Will Save Others -- Oct. 20, 2016
Read more ...
 

Harnessing the Immune System to Fight CancerNew drugs and methods of altering a patient’s own immune cells are helping
some cancer patients — but not all — even when standard treatments fail.  Read more...

Doctors Excited by New Cancer Treatment -- April 4, 2016  
Read more...


Forbes.com.  Man who made a personal fortune off of the cancer drug medivation. Read more...

60 Minutes Overtime - Using polio drug to kill cancer - March 2015…Read more ...

Duke University Medical Center. Clinical Trials for Adults |A Phase I Clinical Trial for Recurrent Glioblastoma Patients Opens for Accrual at the Preston Robert Tisch Brain Tumor Center…
Read more...

Science Daily. An Internet source of the latest research news.
Read news...

National Cancer Institute
. News and events from NCI-funded research and programs.

Read news...

Medical News Today.
  The latest cancer and oncology research from prestigious universities and journals throughout the world.  Read news...


U.S. News
.  Best Hospitals for Adult Cancer.  Read news...


NBC News. The latest news about cancer, photos and video.  Read news...

FOX News. Cancer news.  Read news...

Forbes Magazine. Is This How We’ll Cure Cancer?  Read news...

ABC News. Latest cancer news. Read news... 

CBS News. Latest cancer news. Read news... 

MD Anderson Cancer Center. The University of Texas center news.  Read more ...

American Cancer Society. Cancer news by topic.  Read news...

EurekAlert. American Association for the Advancement of Science (AAAS)
Read more ...

National Institutes of Health. U.S. Department of Health & Human Services news.
General news...

Cancer Centers of America.  Newsletters.
Read news ...